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Abstract 
WNT10B is a member of the WNT ligand gene 
family encoding a secreted growth factor that has 
been reported to have role in a wide range of 
biological actions. Wnt10b was originally identified 
from mouse embryos and the virgin mammary gland, 
the locus was cloned by retroviral insertional 
activation, similar to the strategy used to identify 
other mammary oncogenes. During mammary gland 
development, Wnt10b seems to play a relevant role 
as it is the earliest expressed Wnt ligand. It has been 
well established that transgenic expression of 
Wnt10b in mouse mammary epithelial cells under 
the control of the MMTV promoter leads to 
mammary gland hyperplasia, increased proliferation, 
and branching. Furthermore, WNT10B has epistatic 
activity on HMGA2, which is necessary and 
sufficient for proliferation of triple-negative breast 
cancer. The role of Wnt10b in immune system was 
first described in helper T cells, and its expression in 
preB and proB cell lines suggested an involvement 
in lymphoid development. Furthermore, in CD8 T 
cells Wnt10b is induced by parathyroid hormone 
(PTH), suggesting that Wnt10b is playing an 
important role in T-cell development nad function. 
In a different study increased levels of Wnt10b in the 
bone marrow were found in a regenerative model, in 
which both the stromal cells and HSCs had increased 
Wnt10b expression in response to  
injury. Insight into regenerative processes point to 
WNT10B as a candidate potentially linking tissue 
regeneration and cancer.  
Recently reported evidences support a role of the 
hematopoietic regeneration-associated WNT10B on 
AC133+ cells in human Acute Myeloid Leukemia 
(AML) via a recurrent rearrangement promoted by a 
mobile human transposable-WNT10B oncogene (ht-
WNT10B), as a relevant mechanism for WNT10B 
involvement in human cancer. 
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Identity 
Other names: SHFM6, STHAg8, WNT12 
HGNC (Hugo): WNT10B 
Location: 12q13.2 
Local order: Minus strand DNA. Start at 
48,965,340 and ends at 48,971,858 bp from pter. 
This gene is clustered with another family member, 
WNT1, in the chromosome 12q13 region. 
DNA/RNA 
Description 
DNA size: 6519 bp, DNA linear. Exon count: 6. This 
gene has 6 transcripts (splice variants), 56 
orthologues, 5 paralogues. 
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Transcription 
Six transcript variants encoding different isoforms 
have been found for this gene (font: 
www.ensembl.org).  
WNT10B-001 ENST00000301061.8: mRNA 2274 
bp, protein 389 aa).  
WNT10B-002 ENST00000203957.5: mRNA 1817 
bp, protein 173 aa).  
WNT10B-003 ENST00000407467.5: mRNA 1802 
bp, protein 191 aa).  
WNT10B-004 ENST00000413630.1: mRNA 623 
bp, protein 132 aa).  
WNT10B-005 ENST00000420388.1: mRNA 559 
bp, protein 102 aa).  
WNT10B-006 ENST00000475740.1: mRNA 429 




Hardiman et al., in 1997 isolated and characterized 
fort the first time the gene WNT10B that encodes a 
389-amino acid protein with 96.6% sequence 
identity to mouse Wnt10b. They observed the 
expression pattern of WNT10B in different adult 
tissues with the highest levels found in heart, skeletal 
muscle and in several human cancer cell lines with 
elevated mRNA levels observed in HeLa (cervical 
cancer) cell ( Hardiman et al., 1997).  
Dyregulation of WNT10B is implicated in different 
human pathologies as split hand/foot malformation 
(SHFM) and obesity (Aziz, 2014; VanCamp 2013). 
Wnt Signaling   
Wnt/β-catenin signaling pathway directs cell 
proliferation and cell fate during embryonic 
development and adult homeostasis. Moreover, 
deregulation of Wnt signaling is tightly linked to 
human disease, such as multiple forms of cancer and 
bone malformation (Clevers, 2006; Klaus and 
Birchmeier, 2008). Dysregulation of WNT 
signalling has been implicated in different types of 
cancers, (Lu et al, 2004; Simon et al, 2005; Cadigan 
and Nusse, 1997; Reya and Clevers, 2005), and the 
first direct connection between the Wnt pathway and 
human disease came in the early 1990's. Several 
studies pointed out the important role of the Wnt 
signaling in regulating mitotic divisions of 
hematopoietic stem cells (HSCs) (Reya et al., 2003). 
Wnt proteins were originally identified in 
Drosophila and mice (Nusslein-Volhard and 
Wieschaus, 1980; Nusse and Varmus, 1982), which 
were called Wingless (Wg) and Int1. Cadigan and 
Nusse identified 19 Wnt proteins that are secreted 
lipid-modified glycosylated signaling molecules, 
essential in various developmental processes 
(Cadigan and Nusse, 1997), acting both on the 
secreting cell and neighbouring cells and 10 frizzled 
receptors that can activate the canonical (Wnt/β-
catenin), or non-canonical (Wnt/PCP or Wnt/Ca+) 
Wnt pathways. In the absence of Wnt ligand or 
presence of Wnt antagonists, the axin/adenomatous 
polyposis coli ( APC)/casein kinase 1 ( 
CSNK1A1)/glycogen synthase kinase 3 (GSK3) 
protein complex binds and phosphorylates β-catenin 
( CTNNB1) resulting in ubiquitination and 
proteosomal degradation of β-catenin. The pathway 
is activated when a Wnt ligand binds to the 
transmembrane domain receptor of the Frizzled 
family (FZD) and its co-receptor low-density 
lipoprotein receptor-related protein 5 or 6 ( LRP5/( 
LRP6). Wnt proteins are characterized by an N-
terminal signal sequence and by palmitoylation on a 
conserved cysteine residue, by the protein Porcupine 
( PORCN). Wnt proteins are also characterized by 
cysteine residues and are glycosylated and lipid 
modified at two conserved residues, defining the 
hydrophobic profile of proteins. During the ligand 
receptor interaction, Wnt ligands bind to the 
extracellular N-terminal cysteine-rich domain of the 
Frizzled (FZD) receptor, which is related to the low 
density lipoprotein receptor-related protein 5 or 6 
(LRP5/6). Therefore the cytoplasmic protein 
Dishevelled ( DVL1) is recruited to the receptor 
complex and then CK1 and GSK3β phosphorylates 
the cytoplasmic tail of LRP5/6. Then AXIN1, is 
recruited to the receptor complex and assembly of 
the destruction complex is disrupted. Active 
dephosphorilated β-catenin will accumulate in the 
cytoplasm to translocate into the nucleus, where it 
initiates transcription by activating T cell 
factor/lymphoid enhancer factor (TCF/ LEF1) 
transcription factors. When β-catenin is bound to the 
destruction complex is phosphorylated on Serine 
(Ser) 45 by  CSNK1A1 (CK1α) which primes β-
catenin for the sequential phosphorylation of 
Threonine (Thr) 42, Ser 39, and Ser 37 by GSK3β. 
This phosphorylation of β-catenin promotes the 
recognition by an E3 ubiquitin ligase, which leads to 
the ubiquitination and proteasomal degradation of β-
catenin. In the absence of β-catenin TCF is linked to 
a transcriptional repressor complex with Groucho, a 
protein which is physically displaced by β- catenin 
(Clevers, 2006; Logan and Nusse, 2004; MacDonald 
et al., 2009; Mosimann et al., 2009; Staal and 
Clevers, 2005). Under unstimulated conditions, β-
catenins are rapidly turned over by ubiquitination 
and degradation by the proteasome pathway. This 
requires phosphorylation of β-catenin by a 
"degradation complex" consisting of APC, Axin, 
GSK3, and CK1, followed by binding of BTRC (β -
Trcp) (Rubinfeld et al., 1996; Munemitsu et al.; 
Willert and Jones, 2006). Signals induced by Wnt 
proteins interrupt the formation of the degradation 
complex, there by preventing the phosphorylation 
and destruction of β-catenin. 
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Expression 
In human WNT10B is expressed in different tissues 
and organs, including bone marrow, whole blood, 
lymph node, thymus, cerebellum, brain, retina, 
spinal cord, heart, smooth muscle, skeletal muscle, 
small intestine, colon, adipocyte, kidney, liver, lung, 
pancreas, thyroid, salivary gland, adrenal gland, 
skin, ovary, uterus, placenta, cervix and prostate 
(http://www.genecards.org/cgi-
bin/carddisp.pl?gene=WNT10B).  
Aprelikova et al., showed that MIR148A is 
downregulated in 94% of cancer-associated 
fibroblasts (CAFs) compared with matched normal 
tissue fibroblasts (NFs) established from patients 
with endometrial cancer. They revealed that 
WNT10B is a direct target of MIR148A in CAFs 
from endometrial cancers and demonstrated that its 
upregulation in these cells increases tumor cell 
motility (Aprelikova et al., 2013) 
Localisation 
WNT10B is a ligand secreted glycoprotein found 
mainly in the extracellular compartment. WNT10B 
proteins bind to the extracellular N-terminal 
cysteine-rich domain of the Frizzled (FZD) 
receptors, which is in a complex with the low density 
lipoprotein receptor-related protein 5 or 6 (LRP5/6). 
FZD receptors are seven-pass transmembrane 
receptors which have cycteine-rich domains (CRD) 
in their N-terminus. Through the CRD, FZD receptor 
binds Wnt ligands. 
Function 
It was demonstrated that Wnt10b is expressed in 
cardiomyocytes and stored in the intercalated discs 
both in normal human and mouse hearts. Recently, 
Palk et al., evidenced that after injury, Wnt10b 
expression is upregulated in cardiomyocytes during 
the granulation tissue formation phase of cardiac 
repair, leading an increased angiogenesis by 
induction of KDR (vascular endothelial growth 
factor receptor 2, Vegfr-2) expression, formation of 
coronary-like vessels surrounded by vascular 
smooth muscle cells (vSMCs) via induction of 
ANGPT1 (angiopoietin-1) and cardiomyogenesis 
within scar tissue. The authors, highlighetd the role 
of Wnt10b in a cardiac repair by arteriole formation 
reducing the fibrosis and stimulating arteriole 
formation in NF-KB-dependent manner (Paik et al., 
2015).  
Davis et al., demonstrated that Wnt/beta-catenin 
signaling is a major regulator of mesenchymal stem 
cells fate (Davis et al., 2008). Matsushita et al., 
reported that Wnt10b/beta-catenin signaling is 
considered to act as a brake for adipogenic 
differentiation, suggesting an important role of 
Wnt10b as an endogenous regulator of adipogenesis. 
In addition, Matsushita et al., in their study 
demonstrated that AGTR2 (angiotensin II type 2 
receptor) inhibits adipocyte differentiation of murine 
MSCs with Wnt10b/beta-catenin signaling, 
suggesting a strong interaction between 
Wnt10b/beta-catenin signaling and the the renin-
angiotensin system (RAS), and providing important 
insights into the pathophysiology of obesity and 
obesity-related consequences (Matsushita et al., 
2016).  
Lei et al., evidenced in 2014 that in response to 
prolonged ectopic Wnt10b-mediated β-catenin 
activation, regenerating anagen hair follicles grew 
larger in size. These results were confirmed by 
Zhang et al., who provided the evidence that Wnt10b 
can induce hair follicle regeneration, in a time 
dependent manner, because a prolonged 
overexpression of Wnt10b induced an abnormal hair 
follicle regeneration by epidermal keratinocyte 
transformation, whereas transient overexpression of 
Wnt10b induces only hair follicle regeneration. They 
found that Wnt10b promoted the proliferation of hair 
follicle stem cells from 24 hours after Adenovirus 
vector AdWnt10b injection, and after seventy-two 
hours from AdWnt10b injection, cells outside of 
bulge area began to proliferate, providing the 
evidence that the overexpression of WNT10B might 
activate the hair follicle stem cells (HFSCs) inducing 
hair follicle regeneration (Lei et al., 2014; Zhang et 
al., 2016).  
The role of Wnt10b in immune cells was first 
described in helper T cells (Hardiman et al., 1996), 
Wnt10b mRNA has been found during thymic 
development at embryonic day 13 (E13), and it is 
also found in the adult thymus (Balciunaite et al. 
2002), suggesting that it should play a critical role, 
in an intrathymic T-cell development. Furthermore, 
it was demonstrated that in CD8+ T cells Wnt10b is 
induced by parathyroid hormone (PTH) in an 
osteoporosis model (Terauchi et al. 2009).  
Wolf et al, in 2016 examined the interaction between 
PTH (parathyroid hormone) and WNT10B in 
periodontal regeneration, evidencing the interplay of 
T cells and human periodontal ligament (hPDL) cells 
via the WNT10B pathway as a modulating factor for 
the anabolic properties of the hormone in periodontal 
regeneration.  
During last years, the research group of Miranda-
Carboni showed that Wnt10b has an important role 
during the mammary gland development, bacause is 
expressed at the earliest time during differentiation 
of the mammary placode (Veltmaat et al. 2004;), 
suggesting that Wnt10b could be the placode 
specifier.  
Its specific role remains to be investigated. 
Moreover, Hamamoto et al highlighted that 
SMYD3upregulates WNT10B as a direct 
downstream gene and could promote breast 
carcinogenesis by directly regulating expression of 
the proto-oncogene WNT10B (Hamamoto et al., 
2006).  
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Recently, Yu et al, in 2016 revealed a heterozygous 
missense mutation (c.632G>A [p.Arg211Gln]) in 
WNT10B in all family members affected by 
oligodontia, a severe form of tooth agenesis, is 
genetically and phenotypically a heterogeneous 
condition (Yu et al., 2016).  
Finally, Beghini et al, in 2012 examining the role of 
Wnt signaling in acute myeloid leukemia, provided 
direct evidence of a ligand-dependent activation of 
the regeneration-associated Wnt pathway (Congdon 
et al, 2008), defining the term "regeneration" as the 
physiological phenomena of reconstitution from 
injury requiring rapid expansions of HSCs by 
reactivation of developmental pathways (Angers and 
Moon, 2009; Bowman, et al., 2012). They revealed 
that the ligand-dependent Wnt signaling is induced 
in AML through a diffuse expression and release of 
WNT10B, a hematopoietic stem cells regenerative-
associated molecule (Beghini et al., 2012). 
Homology 
The WNT10B gene is conserved in chimpanzee, 
Rhesus monkey, dog, cow, mouse, rat, zebrafish, 
fruit fly, mosquito, and frog. 
Implicated in 
Acute Myeloid Leukemia 
Recently, Beghini et al., evidenced that the 
regenerative function of WNT signaling pathway is 
defined by the up-regulation of WNT10B, 
WNT10A, WNT2B and WNT6 loci, revealing that 
the ligand-dependent Wnt signaling is induced in 
Acute Myeloid Leukemia patients, through a diffuse 
expression and release of WNT10B, a hematopoietic 
stem cells regenerative-associated molecule. 
WNT10B was identified as a major locus associated 
with the regenerative function and over-expressed in 
bone marrow sections of all AML patients. The Wnt 
signaling activation signature represented by 
accumulation of the active form of dephosphorylated 
beta-catenin (ABC), is shared by only the 
subpulation of AC133bright AML cells (8-10 μm 
diameter of the nuclei), likely induced through an 
autocrine/paracrine mechanism. Using the mRNA in 
situ detection, a new molecular tool for the mRNA 
molecules detection directly in situ, they evidenced 
the constitutive activation of WNT10B transcription 
in the Bone Marrow (BM) sections derived from 
AML patients, suggesting that the regenerative 
WNT signaling is a stem cell-associated function 
altered in AML stem cell fraction (Beghini et al., 
2012).  
By the molecular evaluation of the WNT10B locus, 
it was identified the presence of a recurrent 
rearrangement that generate the WNT10BR allele, 
within intron 1 (IVS1) and flanked at the 5' by an 
unknown non-human sequences (Lazzaroni et al., 
2016). The expression of the transcript variant 
(WNT10BIVS1) was restricted in a cohort of patients 
with intermediate/unfavorable risk AML. It has also 
been identified at genomic level an intronless 
WNT10B oncogene short form named ht-WNT10B, 
and characterized by the 77 IVS1 nucleotides in the 
5'-flanking region, the absence of exons 1 and 4, and 
the presence of a G/A single nucleotide variation at 
the exon junction 2-3. The ht-WNT10B suggests its 
involvement in a non-random microhomology-
mediated recombination generating the rearranged 
WNT10BR (Lazzaroni et al., 2016). 
Endometrial Cancer 
Chen et al., recently demonstrated that the positive 
expression of WNT10B molecule in cancerous 
endometrial tissues, was higher than hyperplastic or 
normal endometrium. They identified that difference 
in Wnt10b levels was significant among cancer 
subgroups for histological type, grade of 
differentiation, and lymphovascular metastasis. 
During the follow-up, it was demonstrated that 
WNT10B gene expression was frequently 
upregulated in Endometrial Cancer (EC) and 
associated with better prognosis in EC patients, 
suggesting that WNT10B expression is stage-
dependent.  
Collectively, the authors suggested that the up-
regulation of WNT10B may contribute to 
Endometrial Cancer with favorable prognosis, 
characterized by high-grade, advanced-stage and no 
lymph node metastasis (Chen et al., 2012). 
Prostate Cancer 
Recently it was revealed that WNT10B molecule is 
upregulated in prostate cancer reactive stroma and it 
is expressed in the prostate stromal cell lines, by 
decreasing apoptosis in LNCaP cancer cells and 
increasing angiogenesis. The authors identified an 
autocrine stimulation of expression of stem cell 
associated genes as BDNF that enhances VEGFA 
expression in an autocrine manner. These findings 
suggested the WNT10B role in regulating expression 
of genes associated with mesenchymal stem cell 
biology in prostate stroma as it does in bone and 
adipose tissue (Dakhova et al., 2014). 
Breast cancer 
Bui et al., in 1997 have isolated as the first time, a 
WNT gene which has not previously been described 
in human, a human homologue of mouse Wnt10b 
(Bui et al., 1997). According to their research, the 
high WNT10B mRNA expression in different breast 
cell lines, was strictly related to mammary gland 
development and disease. Following this point of 
view, Lane et al., provided the evidence that 
overexpression of WNT10B leads the branching of 
mammary ducts and the alveolar development. 
Indeed, Veltmaat et al., in 2004 evidenced that 
Wnt10b expression is the earliest fundamental 
ectodermal event (E11.25) defining the mammary 
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gland ridge and mammary lineage (Veltmaat et al, 
2004).  
Recently, Wend et al., highlighted that the elevated 
expression of Wnt10b results in mouse mammary 
tumorigenesis, and it has been also revealed in 
human breast carcinoma cell lines (Wend et al, 
2011). They have also demonstrated that human 
triple-negative breast cancers (TNBC) express 
WNT10B, that activates canonical β-catenin 
signalling leading to proliferation and up-regulation 
of HMGA2, the high-mobility group A protein 
highly expressed in breast cancer (Peluso and 
Chiappetta, 2010) that is significantly correlated 
with the capacity to predict metastasis in their TNBC 
cohort of patients.  
By culturing MCF-7 cell line in conditions that form 
spheres they exhibit more cancer stem cell like 
features, (e.g. expressing AC133+), it has been 
detected the WNT10B-FZDs interacting complexes 
using the in situ Proximity Ligation Assay molecular 
tool, providing evidences for an autocrine activation 
primed by the formation of WNT10B-FZD4/5 
complexes (Lazzaroni et al., 2016). 
Osteosarcoma 
According to Chen et al., Human Osteosarcoma 
(OS) tumor samples that express WNT10B have 
reduced likelihood of survival compared to OS that 
lack WNT10B expression, suggesting that Wnt 
signaling may play an important role in OS 
tumorgenesis and metastasis (Kevin Chen BS et al., 
2008).  
Recently, Modder et al., demonstrated that 
WNT10B, stimulates the NFKB and Notch 
pathways in the U2OS osteosarcoma cancer cell 
model, suggesting that WNT10B can activate the 
Notch pathway as a mechanism to inhibit 
differentiation in osteosarcoma, perhaps leading to a 
more aggressive tumor (Modder et al., 2011). 
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